Your browser doesn't support javascript.
loading
Ryanodine receptor inhibition with acute dantrolene treatment reduces arrhythmia susceptibility in human hearts.
George, Sharon A; Brennan-McLean, Jaclyn A; Trampel, Katy A; Rytkin, Eric; Faye, N Rokhaya; Knollmann, Bjorn C; Efimov, Igor R.
Affiliation
  • George SA; Department of Biomedical Engineering, George Washington University, Washington, District of Columbia, United States.
  • Brennan-McLean JA; Department of Biomedical Engineering, Northwestern University, Chicago, Illinois, United States.
  • Trampel KA; Department of Biomedical Engineering, George Washington University, Washington, District of Columbia, United States.
  • Rytkin E; Department of Biomedical Engineering, George Washington University, Washington, District of Columbia, United States.
  • Faye NR; Department of Biomedical Engineering, Northwestern University, Chicago, Illinois, United States.
  • Knollmann BC; Department of Biomedical Engineering, George Washington University, Washington, District of Columbia, United States.
  • Efimov IR; Department of Biomedical Engineering, Northwestern University, Chicago, Illinois, United States.
Am J Physiol Heart Circ Physiol ; 325(4): H720-H728, 2023 10 01.
Article in En | MEDLINE | ID: mdl-37566110
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ryanodine Receptor Calcium Release Channel / Heart Failure Limits: Humans Language: En Journal: Am J Physiol Heart Circ Physiol Journal subject: CARDIOLOGIA / FISIOLOGIA Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ryanodine Receptor Calcium Release Channel / Heart Failure Limits: Humans Language: En Journal: Am J Physiol Heart Circ Physiol Journal subject: CARDIOLOGIA / FISIOLOGIA Year: 2023 Type: Article Affiliation country: United States